# THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS

> **NCT06124066** · PHASE4 · COMPLETED · sponsor: **Hasanuddin University** · enrollment: 42 (actual)

## Conditions studied

- Ureteral Stone
- Kidney Stones
- Ureteral Stenosis

## Interventions

- **DRUG:** Mirabegron 50 MG

## Key facts

- **NCT ID:** NCT06124066
- **Lead sponsor:** Hasanuddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06124066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06124066, "THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06124066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*